Amgen Inc. can pursue a patent lawsuit that seeks to block Roche Holding from selling the anemia drug Cera in the U.S., a judge ruled Friday, agreeing to a timetable that may lead to a trial as early as May. U.S. District Judge William G. Young in Boston rejected Roche's request that the suit be thrown out because Cera isn't yet sold in the U.S. The Food and Drug Administration may decide in February whether to approve the drug, used to boost red blood cells, Amgen said.

Posted by GEN-ERIC at 12:17:30 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/892

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)